MDT250110P76000
- 0.47
- 0.000.00%
Medtronic Newsroom
Bernstein Adjusts Price Target on Medtronic to $93 From $97, Keeps Outperform Rating
Bernstein Maintains Medtronic(MDT.US) With Buy Rating, Cuts Target Price to $93
S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today
Johnson & Johnson Falls After Pausing Varipulse Cases
State-of-the-Art Intraoperative 3D Imaging Now Offered at Nicklaus Children's Hospital
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Medtronic Spinal Division Inks Agreement With Kuros Biosciences
Piper Sandler Maintains Medtronic(MDT.US) With Hold Rating
Hysteroscopy Instruments Market Research 2024-2028 & 2033 Featuring Major Players - Medtronic, Fujifilm, Stryker, Boston Scientific, and B. Braun Melsungen
Implantable Neurostimulation Devices Market Research 2024-2028 & 2033, Competitive Analysis of Major Players - Abbott Laboratories, Medtronic, Boston Scientific, Dignity Health, & St. Jude Medical
Is Medtronic's Dividend Safe?
Bernstein Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $97
RBC Capital Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $105
RBC Capital Sticks to Its Buy Rating for Medtronic (MDT)
Diabetes Device Maker Beta Bionics Files for $100M IPO
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
Fire1 Raises $120M for Breakthrough Heart Failure Management Tech With Investment From Medtronic
Market Sells CES Tech News, ISM Tuesday as Nvidia Champions Robots Monday | Live Stock
Endologix Announces Leadership Transition